Publications by authors named "Mary Todd"

Claim this Profile
S
Substrates with Tunable Hydrophobicity for Optimal Cell Adhesion.
Yuriy Snyder, Mary Todd, Soumen Jana

Macromol Biosci· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naïve prostate cancer: a subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, Phase 3 study.
Satoshi Fukasawa, Hiroyoshi Suzuki, Kazushiro Kawaguchi, Hidehisa Noguchi, Kentaro Enjo, Mary Todd

Jpn J Clin Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castration-naive prostate cancer (LATITUDE): an international, randomised phase 3 trial.
Kim N Chi, Andrew Protheroe, Alfredo Rodríguez-Antolín, Gaetano Facchini, Henrik Suttman, Mary B Todd

Lancet Oncol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of subsequent metastases on costs and medical resource use for prostate cancer patients initially diagnosed with localized disease.
Tracy T Li, Neal D Shore, Maneesha Mehra, Mary B Todd, Ryan Saadi

Cancer· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes from Androgen Signaling-directed Therapy after Treatment with Abiraterone Acetate and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302.
Matthew R Smith, Fred Saad, Dana E Rathkopf, Peter F A Mulders, Johann S de Bono, Mary B Todd

Eur Urol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer.
Karim Fizazi, NamPhuong Tran, Luis Fein, Nobuaki Matsubara, Alfredo Rodriguez-Antolin, Mary B Todd

N Engl J Med· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302.
Johann S de Bono, Matthew R Smith, Fred Saad, Dana E Rathkopf, Peter F A Mulders, Mary B Todd

Eur Urol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease and Treatment Characteristics of Men Diagnosed With Metastatic Hormone-Sensitive Prostate Cancer in Real Life: Analysis From a Commercial Claims Database.
Thomas W Flaig, Ravi C Potluri, Yvette Ng, Mary B Todd, Maneesha Mehra

Clin Genitourin Cancer· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low Incidence of Corticosteroid-associated Adverse Events on Long-term Exposure to Low-dose Prednisone Given with Abiraterone Acetate to Patients with Metastatic Castration-resistant Prostate Cancer.
Karim Fizazi, Kim N Chi, Johann S de Bono, Leonard G Gomella, Kurt Miller, Mary B Todd

Eur Urol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Prostate Cancer Clinical States and Mortality in the United States: Estimates Using a Dynamic Progression Model.
Howard I Scher, Kirk Solo, Jason Valant, Mary B Todd, Maneesha Mehra

PLoS One· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeated measures analysis of patient-reported outcomes in prostate cancer after abiraterone acetate.
David Cella, Susan Li, Tracy Li, Thian Kheoh, Mary B Todd

J Community Support Oncol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment evolution for metastatic castration-resistant prostate cancer with recent introduction of novel agents: retrospective analysis of real-world data.
Thomas W Flaig, Ravi C Potluri, Yvette Ng, Mary B Todd, Maneesha Mehra

Cancer Med· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updated interim efficacy analysis and long-term safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients without prior chemotherapy (COU-AA-302).
Dana E Rathkopf, Matthew R Smith, Johann S de Bono, Christopher J Logothetis, Neal D Shore, Mary B Todd

Eur Urol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial.
Cora N Sternberg, Daniel Castellano, Gedske Daugaard, Lajos Géczi, Sebastien J Hotte, Mary B Todd

Lancet Oncol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interactions of abiraterone, eplerenone, and prednisolone with wild-type and mutant androgen receptor: a rationale for increasing abiraterone exposure or combining with MDV3100.
David End, Arturo Molina, Mary Todd, Michael L Meyers

Cancer Res· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fast and flawed or scientifically sound: the argument for administering oral oncology drugs during fasting.
Mary Todd, Michael L Meyers, Robert Charnas, Milin Acharya, Arturo Molina

J Clin Oncol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Teaching memory-impaired people to touch type: the acquisition of a useful complex perceptual-motor skill.
Mary Todd, Corinne Barrow

Neuropsychol Rehabil· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COX-2 inhibitor safety in the workers' compensation market.
Matthew Foster, Ralph Kendall, Mary Todd,

Lippincotts Case Manag· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of docetaxel and vinorelbine in patients with hormone-refractory prostate cancer.
Susan Goodin, Kamakshi V Rao, Michael Kane, Nisha Dave, Terry Capanna, Mary Todd

Cancer Chemother Pharmacol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of docetaxel in patients with hormone-dependent prostate-specific antigen progression after local therapy for prostate cancer.
Susan Goodin, Patrick Medina, Terry Capanna, Weichung J Shih, Sybil Abraham, Mary Todd

J Clin Oncol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-institutional phase II trial of gemcitabine plus paclitaxel in patients with locally advanced or metastatic urothelial cancer.
Donald S Kaufman, Michael A Carducci, Tim M Kuzel, Mary B Todd, William K Oh

Urol Oncol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meperidine and the management of pain: what you need to know.
Mary Todd

Lippincotts Case Manag· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of weekly docetaxel with concurrent three-dimensional conformal radiation therapy in the treatment of unfavorable localized adenocarcinoma of the prostate.
Parvesh Kumar, Michael Perrotti, Robert Weiss, Mary Todd, Susan Goodin

J Clin Oncol· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longer term assessment of photodynamic therapy for intimal hyperplasia: a pilot study.
Justin Cheung, Mary Todd, Robert Turnbull, Beth Allison, Lorna Mornin

J Photochem Photobiol B· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antineoplastic effects of partially HLA-matched irradiated blood mononuclear cells in patients with renal cell carcinoma.
Roger K Strair, Dale Schaar, Daniel Medina, Mary B Todd, Joseph Aisner

J Clin Oncol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis